Clinic
Elite Care Family Medicine, LLC
Elite Care Family Medicine, LLC was paid $2.43M by Medicaid between Jan 2018 and Dec 2024, across 43 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoELITE CARE FAMILY MEDICINE, LLC
GUNTOWN, MS 38849
GUNTOWN, MS 38849
33aNPI1194128306assigned 10/01/2014
33bProvider typePrimary Care Clinic/Center
28Total paid$2.43M
24GClaims109,461
24DCodes billed43
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Mississippi
Rank by total paid#8 of 85
Median peer was paid$100K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,727 | $121K | |
| 2019 | 5,714 | $172K | |
| 2020 | 7,371 | $235K | |
| 2021 | 24,300 | $554K | |
| 2022 | 34,223 | $585K | |
| 2023 | 21,342 | $459K | |
| 2024incomplete | 12,784 | $302K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 14,216 | 11,704 | $660K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 22% | 9,240 | 7,799 | $543K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 8,614 | 6,933 | $527K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 11% | 8,451 | 6,805 | $256K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.8% | 6,048 | 5,217 | $141K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.5% | 8,131 | 6,829 | $108K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.8% | 5,777 | 4,400 | $67K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.3% | 550 | 516 | $57K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 241 | 219 | $17K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,261 | 1,134 | $13K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 195 | 169 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 704 | 281 | $7K |
31 more codes
| 87807 | <1% | 561 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,879 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 85 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 517 | $2K |
| 81002 | <1% | 1,037 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,497 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 114 | $2K |
| 84703 | <1% | 286 | $1K | |
| 87430 | <1% | 102 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 538 | $875.39 |
| 0001A | <1% | 21 | $667.14 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 916 | $571.29 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 22 | $420.00 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 51 | $390.57 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,429 | $377.28 |
| 90756 | <1% | 15 | $341.85 | |
| 90715 | <1% | 20 | $238.32 | |
| 80053 | Comprehensive metabolic panel | <1% | 17 | $85.50 |
| 3075F | 0% | 583 | $0.00 | |
| 3008F | 0% | 7,236 | $0.00 | |
| 3074F | 0% | 4,736 | $0.00 | |
| 1036F | 0% | 4,902 | $0.00 | |
| 3079F | 0% | 1,446 | $0.00 | |
| 3080F | 0% | 796 | $0.00 | |
| 1126F | 0% | 14 | $0.00 | |
| 1125F | 0% | 32 | $0.00 | |
| 3078F | 0% | 3,437 | $0.00 | |
| 3077F | 0% | 440 | $0.00 | |
| 1160F | 0% | 8,259 | $0.00 | |
| 90714 | 0% | 18 | $0.00 | |
| S0077 | Injection, clindamycin phosphate, 300 mg | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMILLER, KEVIN (CO OWNER)
| Provider | Location | Paid |
|---|---|---|
| Cnetral Islip Ufsd | Central Islip, NY | $1.75M |
| Hicksville Exempted Village Schools | Hicksville, OH | $191K |
| Miller Psychiatric Services, LLC | Austintown, OH | $75K |
| Goodwill Mennonite Home, INC. | Grantsville, MD | $34K |
| Ep True Chiropractic INC. | West Des Moines, IA | $15K |
| Charleston R-1 School District | Charleston, MO | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.